Czech Society for Metabolic Skeletal Diseases CSMBD - SMOS
Osteoporosis is a major disease of mass occurrence representing a major health and social problem. This is a generalized systemic skeletal disease, characterized by reduced bone strength. Reduced bone strength is due to changes in the quantity and quality of bone mass and predispose to an increased risk of fractures. In the presence of one or more osteoporotic fractures can talk about osteoporosis. Attribution of specific osteoporosis fractures may be difficult in individual cases. Fractures are numerous in individuals with osteopenia or normal bone mass. Whether it is possible to identify fracture in patients with low bone mass for osteoporotic fracture should arise from the evaluation of the overall context, incl. the clinical condition of the patient and accident happening. In the Czech Republic, osteoporosis affects 15% of men and 33% of women aged over 50 and 39% of men and 47% of women aged over 70 years. Overall, osteoporosis affects over 5% of the population. The consequence of this disease are fractures, especially vertebral and hip fractures. These fractures significantly impair quality and shorten life expectancy. Age-specific incidence of hip fractures in the last 20 years in the Czech Republic and doubled in this fractured annually suffer 4% of all women older than 85 years. These fractures result in a fifth of disabled persons during the first year after the accident and the death of up to half of patients depending on help. Fractures can be prevented with appropriate measures. These relate to early identification of persons at increased risk of osteoporosis and fractures and other measures to eliminate modifiable risk factors, as well as pharmacological actions, and finally verify the effectiveness of these measures. These areas are the subject of these guidelines. This recommendation has been prepared on the basis of published opinions of the World Health Organization (WHO), the International Osteoporosis Foundation (IOF) Recommendation umbrella union osteological companies in German-speaking countries for prevention, diagnosis and treatment of osteoporosis, the American Association of Clinical Endocrinology, Belgium osteological companies and Canadian Society for osteoporosis, official position of the International Society for Clinical densitometry (ISCD) and the previous version of the Recommended Practices for diagnosis and treatment of postmenopausal osteoporosis Society for Metabolic Bone Diseases Czech Medical Association in 2003 .